TCOV
STJ

Trust Company of Vermont’s St Jude Medical STJ Stock Holding History

Trust Company of Vermont’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-74
Closed -$6K – 974
2016
Q4 		$6K Hold
74
– – ﹤0.01% 769
2016
Q3 		$6K Hold
74
– – ﹤0.01% 732
2016
Q2 		$6K Hold
74
– – ﹤0.01% 690
2016
Q1 		$4K Hold
74
– – ﹤0.01% 683
2015
Q4 		$5K Hold
74
– – ﹤0.01% 689
2015
Q3 		$5K Hold
74
– – ﹤0.01% 707
2015
Q2 		$5K Buy
+74
New +$5.35K ﹤0.01% 732
2013
Q4 		– Sell
-49
Closed -$3K – 751
2013
Q3 		$3K Buy
+49
New +$2.52K ﹤0.01% 672

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Trust Company of Vermont's STJ Position: Q1 2017 in Review

Trust Company of Vermont sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 74 shares — an estimated $6K sold.

Trust Company of Vermont first reported a position in STJ in Q3 2013 and held it in 8 quarters. The position peaked at $6K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Trust Company of Vermont reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Trust Company of Vermont sold 74 St Jude Medical shares in Q1 2017, an estimated $6K.
  • Trust Company of Vermont first reported a position in St Jude Medical in Q3 2013 and held it in 8 quarters.
  • Trust Company of Vermont's St Jude Medical position peaked at $6K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Trust Company of Vermont's 13F filing for Q1 2017, filed 4 May 2017.